GHO Capital completed the acquisition of Validant.

GHO Capital, the European specialist investor in healthcare, completed the acquisition of a majority stake in Validant, a quality, compliance and regulatory affairs consulting firm. Financial terms were not disclosed. “We look to partner with businesses that are or who can become industry leaders. Validant is such a business and offers a unique growth platform in a highly fragmented growth market. We are confident that we will be able to harness GHO’s transatlantic capabilities to support Validant as it expands its operations both in Europe and globally,” Mike Mortimer, GHO Capital Executive Partner.